idiopathic pulmonary fibrosis
Conditions
Interventions
None listed
Sponsors
Department of Respiratory Medicine and Allergology, Kinki University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with IPF diagnosed with ATS/ERS/JRS/ALAT guideline 2011 2) Without any infection and acute exacerbation within 3 mo 3) Written informed consent
Exclusion criteria
Exclusion criteria: 1) Patients with uncontrolled comorbidities 2) Patients who cannot undergo pulmonary function test and/or 6-min walk test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Daily activity measured by an accelerometer 2) Pulmonary function test 3) Arterial blood gas analysis 4) 6-min walk test | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Daily dyspnea (BDI, modified MRC) 2) Health-related quality of life (SGRQ) 3) Depression (HADS) 4) Mental status (MMSE) | — |
Countries
Japan
Contacts
Public ContactOsamu Nishiyama
Kinki University School of Medicine Department of Respiratory Medicine and Allergology
Outcome results
None listed